The International Union of Basic and Clinical Pharmacology, The British Pharmacological Society, The University of Edinburgh
Sweeteners & Flavors Sugar : Must be free from non-halal ingredients, processing aid, and/or contact with any other non-halal raw materials
This review study analyzes human and animal trials of various GLP-1 medications for their role in addressing the hallmarks of aging, such as mitochondrial function and oxidative stress, including low-dose protocols via injection for Parkinson's patients on exenatide
Unlocking the path to obesity treatment: GLP-1 Drugs have proven remarkably effective in managing weight, rivaling surgical procedures like gastric bypass
[7] Frias, J.P., et al
TRIUMPH-1 (80 Weeks) The pivotal TRIUMPH-1 obesity trial (2,339 adults, no diabetes), presented at ADA 2026, extended the treatment window to 80 weeks and produced the largest pivotal weight-loss readout to date: Among the 12 mg group, 45.3% lost at least 30% of their body weight and 65.3% ended the trial with a BMI below 30